The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children.
about
Prediction of delayed recovery from pediatric community-acquired pneumonia.Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia.Differentiation between mycoplasma and viral community-acquired pneumonia in children with lobe or multi foci infiltration: a retrospective case study.Differences upon admission and in hospital course of children hospitalized with community-acquired pneumonia with or without radiologically-confirmed pneumonia: a retrospective cohort study.Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired PneumoniaCarers' perspectives on the presentation of community-acquired pneumonia and empyema in children: a case seriesPediatric respiratory infections by Mycoplasma pneumoniae.Biomarkers: a definite plus in pneumonia.Determining the microbiological cause of a chest infection.Community-Acquired Pneumonia in the Conjugate Vaccine Era.Biomarkers in Pediatric Community-Acquired Pneumonia.Risk factors for community-acquired pneumonia in pre-school-aged children.Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.Clinical and laboratory characteristics of viral lower respiratory tract infections in preschool children.Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections.Diagnostic features of community-acquired pneumonia in children: what's new?International guidelines on tackling community-acquired pneumonia show major discrepancies between developed and developing countries.Pneumonia in children: more shadows than lights.Respiratory Viruses and Atypical Bacteria Co-Infection in Children with Acute Respiratory InfectionIncreased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia
P2860
Q34060794-110C1CD0-3837-46D1-8737-9F291409335EQ34277539-FD62FD4B-84B2-4D7E-88CE-0EADAC7940F8Q34981418-C78FBCC1-8F64-42C7-921F-EDF07557DF1DQ35819523-5672D547-BF41-410E-8A64-85B39988A990Q36192583-FCE26E8D-69CF-40C3-93D6-753E45E66031Q36220140-AC2DC54D-C234-4587-8A19-EFEA621E067DQ37228742-DD910450-25AF-4B75-90AA-E005CA9A0956Q37450352-B01107FC-42CC-45E8-8D82-908D5E6ED805Q38253306-7B1C7307-E222-4A75-A9FF-D3D3A0382AEDQ38653326-E98EF0F2-D59C-4771-AEDA-D4A67186944FQ39144356-852FAAF2-FA38-4000-8CCC-24F8FE8DC353Q40007538-E6D1E684-7EFF-4A3C-A8FB-1DDB99A24DFCQ40298613-B6A56C9C-737C-4840-B0F4-A6EEBD57831DQ40997859-456E4F02-2EC6-4E3F-B521-C4008500AF3CQ41993426-79F0E645-F763-4B06-8FCB-1DD93CCBF7F1Q42249657-E3129CFB-EDA1-469B-8C9E-526EA93F92E6Q44318176-821EB399-D048-4F10-AC65-0D988EEC2FE4Q50800583-C39C2C77-8CC4-4628-8B1F-764885191FB2Q58564735-ABD33232-61BD-431B-8D6F-1A3D1EA2D42CQ58777127-7A2CFB44-8548-4564-B0B3-A9433AE81856
P2860
The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The value of clinical features ...... cterial pneumonia in children.
@en
type
label
The value of clinical features ...... cterial pneumonia in children.
@en
prefLabel
The value of clinical features ...... cterial pneumonia in children.
@en
P2093
P2860
P1433
P1476
The value of clinical features ...... cterial pneumonia in children.
@en
P2093
Mario Canciani
Massimiliano Don
Matti Korppi
P2860
P304
P356
10.1111/J.1651-2227.2008.00789.X
P407
P577
2008-04-15T00:00:00Z